IKBKB and ovarian cancer: In ovarian cancer, downregulated miR-199a, a regulator of IKK-β expression, promoted a functional TLR–MyD88–NF-κB pathway and induced ovarian cancer cells to secret proinflammatory cytokines and enhance tumor progression (66).